AFP and hepatocellular carcinoma: Serum cfDNA levels are significantly higher in HCC patients than in control subjects and are associated with tumor size and differentiation but not age, gender, TNM stage or the levels of AFP or des-γ-carboxy prothrombin (DCP) [14].